New AI Model Helps Spot Normal Breast Screening Exams and Reduces DBT Workloads for Radiologists
|
By MedImaging International staff writers Posted on 21 Jan 2022 |

An artificial intelligence (AI) model was able to identify normal digital breast tomosynthesis (DBT) screening examinations, which decreased the number of examinations that required radiologist interpretation in a simulated clinical workflow.
Researchers from the University of Haifa (Haifa, Israel) conducted a study to evaluate the use of AI to reduce workload by filtering out normal DBT screens. DBT has higher diagnostic accuracy than digital mammography, but interpretation time is substantially longer. Nevertheless, the use of DBT is expected to show progressive growth worldwide, resulting in increased burden for radiologists and higher cost for screening programs. The use of AI models could help save time in the assessment of breast screening examinations and improve reading efficiency.
In the new study, the researchers proposed an AI model to detect cancer-free screening examinations that could be dismissed without consulting a radiologist to reduce workloads. The study included a large DBT screening data set with a substantial number of biopsy-proven examinations (1472 malignant cases and 2232 benign cases) collected from 22 clinical sites. In addition, their AI model examined both the DBT images and the clinical information with each DBT examination. The purpose of the study was to develop an AI model that could filter out normal DBT studies to reduce screening workloads while improving diagnostic accuracy. The researchers also performed a reader study to assess the effect of the use of an AI model in a simulated clinical workflow.
In the retrospective study, the AI model demonstrated the potential to reduce radiologists’ worklist by 39.6%, with improved specificity and non-inferior sensitivity. In a simulated workflow, the recall rate was reduced by 25%. When the team analyzed the AI false-negative findings, it found that almost 70% were occult at mammography. The researchers presented evidence of generalizability of the AI model, both to unseen patients and to unseen sites. AI performance was stable across all age groups, ethnicities, and body mass indexes, suggesting that AI may be widely applicable to diverse patient populations.
In the reader study, the readers had access to all information typically available during screening (such as previous studies and clinical information). The AI standalone performance was non-inferior to that of the mean reader. When worklist reduction for the mean reader was simulated, the specificity increased and recall rate decreased, with maintenance of non-inferior sensitivity. These findings strengthen the potential contribution of AI. Their analysis also showed that although AI performance was better in some metrics and non-inferior in others, its method of analysis is different from that of the human readers. This diversity provides additional support for AI’s potential to augment human decision making.
The researchers have theorized that trusting AI to perform radiologist’s work requires substantial evidence. The team believed that AI should be introduced into clinical practice gradually. Before AI is allowed to automatically interpret complex cases, it will first be used for tasks that are considered repetitive work, which was the approach taken in the study. According to the researchers, with time and with enough accumulated evidence, AI will be trusted in the same way as the results of automated blood tests are trusted.
Related Links:
University of Haifa
Latest General/Advanced Imaging News
- Virtual Staining Technique Creates Histology Images from CT Data
- CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
- AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
- AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
- New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
- Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
- PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
- Multimodal AI Tool Combines CT and Health Records to Predict Heart Risk
- AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
- New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
- 3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
- Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
- Automated AI Tool Detects Early Pancreatic Cancer on Routine CT
- Routine Cardiac CT Enhanced to Predict Heart Failure Risk
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
Breast cancer affects about 2.3 million people each year, creating sustained demand for precise imaging. Dynamic magnetic resonance imaging (MRI) is highly sensitive, yet slow acquisitions hinder real-time... Read more
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read moreUltrasound
view channel
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read more
AI Ultrasound Platform Receives CE Mark for Prenatal Screening
Prenatal ultrasound is central to fetal anomaly screening, yet it remains one of the most technically demanding examinations in routine care. Because both image acquisition and interpretation are highly... Read moreNuclear Medicine
view channelNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read more
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







